Literature DB >> 23053181

Multiple angiogenetic factors are upregulated in POEMS syndrome.

Yuta Yamada1, Setsu Sawai, Sonoko Misawa, Kazuaki Kanai, Kazumoto Shibuya, Masahiro Mori, Junji Moriya, Kazuyuki Sogawa, Haruna Yamamoto, Minako Beppu, Junko Taniguchi, Chiaki Nakaseko, Fumio Nomura, Satoshi Kuwabara.   

Abstract

Polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes (POEMS) syndrome is a multisystem disorder associated with plasma cell dyscrasia. Elevated serum levels of vascular endothelial growth factor (VEGF), which strongly promotes neovascularization and vasopermeability, are considered to be responsible for the characteristic symptoms such as angiomata, pleural effusion/ascites, edema, and organomegaly in the disorder. To study whether other angiogenetic factors are upregulated in POEMS syndrome, we measured serum levels of basic fibroblast growth factor and hepatocyte growth factor (HGF), as well as VEGF, in 17 patients with POEMS syndrome. All these factors were significantly upregulated in the POEMS syndrome patients. After the treatment with anti-VEGF antibody, the levels of HGF did not change, suggesting that elevation of HGF levels is not secondary to VEGF overproduction. These results suggest that different angiogenetic factors might contribute to the pathogenesis of POEMS syndrome, and this fact might contribute to the insufficient clinical effects obtained by suppression of VEGF alone.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23053181     DOI: 10.1007/s00277-012-1583-2

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  9 in total

1.  Correlation between serum level of vascular endothelial growth factor and subfoveal choroidal thickness in patients with POEMS syndrome.

Authors:  Hirotaka Yokouchi; Takayuki Baba; Sonoko Misawa; Setsu Sawai; Minako Beppu; Masayasu Kitahashi; Toshiyuki Oshitari; Satoshi Kuwabara; Shuichi Yamamoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-04       Impact factor: 3.117

2.  Papilloedema is an independent prognostic factor for POEMS syndrome.

Authors:  Rongtai Cui; Shengyuan Yu; Xusheng Huang; Jiatang Zhang; Chenglin Tian; Chuanqiang Pu
Journal:  J Neurol       Date:  2013-10-20       Impact factor: 4.849

3.  High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation.

Authors:  Gordon Cook; Simona Iacobelli; Anja van Biezen; Dimitris Ziagkos; Veronique LeBlond; Julie Abraham; Grant McQuaker; Stefan Schoenland; Alessandro Rambaldi; Kazimierz Halaburda; Maria Rovira; Simona Sica; Jenny Byrne; Ramon Garcia Sanz; Arnon Nagler; Niels W C J van de Donk; Marjatta Sinisalo; Mark Cook; Nicolaus Kröger; Theo De Witte; Curly Morris; Laurant Garderet
Journal:  Haematologica       Date:  2016-09-15       Impact factor: 9.941

4.  Clinical challenges of an oligosecretory plasma cell dyscrasia.

Authors:  Luís Rodrigues; Marta Neves; Helena Sá; Mário Campos
Journal:  BMJ Case Rep       Date:  2013-02-18

Review 5.  Melanocytes and their diseases.

Authors:  Yuji Yamaguchi; Vincent J Hearing
Journal:  Cold Spring Harb Perspect Med       Date:  2014-05-01       Impact factor: 6.915

6.  Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment.

Authors:  T V Kourelis; F K Buadi; M A Gertz; M Q Lacy; S K Kumar; P Kapoor; R S Go; J A Lust; S R Hayman; V Rajkumar; S R Zeldenrust; S J Russell; D Dingli; Y Lin; N Leung; Y L Hwa; W Gonsalves; R A Kyle; A Dispenzieri
Journal:  Leukemia       Date:  2015-12-16       Impact factor: 11.528

7.  Nerve pathologic features differentiate POEMS syndrome from CIDP.

Authors:  Ezequiel A Piccione; Janean Engelstad; Peter J Dyck; Michelle L Mauermann; Angela Dispenzieri; P James B Dyck
Journal:  Acta Neuropathol Commun       Date:  2016-10-31       Impact factor: 7.801

Review 8.  An update on the diagnosis and management of the polyneuropathy of POEMS syndrome.

Authors:  Federica Cerri; Yuri Matteo Falzone; Nilo Riva; Angelo Quattrini
Journal:  J Neurol       Date:  2018-09-27       Impact factor: 4.849

9.  Adenopathy and extensive skin patch overlying plasmacytoma syndrome-the clue to early diagnosis of polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes: A case series and literature review.

Authors:  Elizabeth Guevara Sanchez; César Ramos; Kayadri Ratnarajah; Francisco P Bravo; Manuel A Del Solar; Michelle Le; Elena Netchiporouk
Journal:  SAGE Open Med Case Rep       Date:  2022-04-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.